Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Aldape

Showing results (281-290 of 345) with videos related to

Pageof 35
Sort By:
NPJ Precision Oncology|March 25, 2023
Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signaturePhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Neuro-Oncology|April 4, 2020
Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomasKohei Fukuoka, Yasin Mamatjan, Ruth Tatevossian, et al.
Neuro-Oncology|September 11, 2021
A molecularly integrated grade for meningiomaJoseph Driver, Samantha E Hoffman, Sherwin Tavakol, et al.
Nature Communications|April 20, 2022
Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genesNorman L Lehman, Nathalie Spassky, Müge Sak, et al.
Nature Communications|January 31, 2023
Author Correction: Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genesNorman L Lehman, Nathalie Spassky, Müge Sak, et al.
Cancer Cell|April 20, 2010
Identification of a CpG island methylator phenotype that defines a distinct subgroup of gliomaHoutan Noushmehr, Daniel J Weisenberger, Kristin Diefes, et al.
Neuro-Oncology|January 8, 2025
Development and validation of a molecular classifier of meningiomasAlexander P Landry, Justin Z Wang, Jeff Liu, et al.
Med (New York, N.Y.)|December 13, 2022
Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptomeGal Dinstag, Eldad D Shulman, Efrat Elis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2020
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade GliomaErica H Bell, Peixin Zhang, Edward G Shaw, et al.
Brain Pathology (Zurich, Switzerland)|February 6, 2026
Integrated high-resolution copy number and histomolecular analysis of diffuse hemispheric glioma, H3 G34-mutant reveals universal TP53 abnormalitiesJorge A Trejo-Lopez, Cinthya Zepeda Mendoza, Thomas M Kollmeyer, et al.
Pageof 35

Showing results (281-290 of 345) with videos related to

Sort By:
Pageof 35
NPJ Precision Oncology|March 25, 2023
Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signaturePhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Neuro-Oncology|April 4, 2020
Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomasKohei Fukuoka, Yasin Mamatjan, Ruth Tatevossian, et al.
Neuro-Oncology|September 11, 2021
A molecularly integrated grade for meningiomaJoseph Driver, Samantha E Hoffman, Sherwin Tavakol, et al.
Nature Communications|April 20, 2022
Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genesNorman L Lehman, Nathalie Spassky, Müge Sak, et al.
Nature Communications|January 31, 2023
Author Correction: Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genesNorman L Lehman, Nathalie Spassky, Müge Sak, et al.
Cancer Cell|April 20, 2010
Identification of a CpG island methylator phenotype that defines a distinct subgroup of gliomaHoutan Noushmehr, Daniel J Weisenberger, Kristin Diefes, et al.
Neuro-Oncology|January 8, 2025
Development and validation of a molecular classifier of meningiomasAlexander P Landry, Justin Z Wang, Jeff Liu, et al.
Med (New York, N.Y.)|December 13, 2022
Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptomeGal Dinstag, Eldad D Shulman, Efrat Elis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2020
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade GliomaErica H Bell, Peixin Zhang, Edward G Shaw, et al.
Brain Pathology (Zurich, Switzerland)|February 6, 2026
Integrated high-resolution copy number and histomolecular analysis of diffuse hemispheric glioma, H3 G34-mutant reveals universal TP53 abnormalitiesJorge A Trejo-Lopez, Cinthya Zepeda Mendoza, Thomas M Kollmeyer, et al.
Pageof 35